Proscillaridin

Proscillaridin
Systematic (IUPAC) name
5-[(3S,8R,9S,10R,13R,14S,17R)- 14-hydroxy- 10,13-dimethyl- 3-((2R,3R,4R,5R,6R)- 3,4,5-trihydroxy- 6-methyltetrahydro- 2H-pyran-2-yloxy)- 2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro- 1H-cyclopenta[a]phenanthren- 17-yl]- 2H-pyran- 2-one
OR
3β-Rhamnosido- 14β-hydroxybufa- 4,20,22-trienolide
Clinical data
AHFS/Drugs.com International Drug Names
Identifiers
CAS Number 466-06-8 N
ATC code C01AB01 (WHO)
PubChem CID 5284613
ChemSpider 4447658 YesY
UNII KC6BL281EN YesY
ChEMBL CHEMBL600325 YesY
Chemical data
Formula C30H42O8
Molar mass 530.650
 NYesY (what is this?)  (verify)

Proscillaridin is a cardiac glycoside, a kind of drug that can be used in the treatment of congestive heart failure and cardiac arrhythmia (irregular heartbeat). It is of the bufanolide type and can be obtained from plants of the genus Scilla and in Drimia maritima (Scilla maritima).[1]

References

  1. Kedra, M.; Kedrowa, S. (1968). "Clinical evaluation of Proscillaridin A, a glycoside of Scilla maritima". Polski tygodnik lekarski (Warsaw, Poland : 1960) 23 (19): 714–716. PMID 4876207.


This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.